BLAINTRAVENOUSPOWDER, FOR SOLUTION
Approved
Nov 2023
Lifecycle
Growth
Competitive Pressure
30/100
Clinical Trials
1
Mechanism of Action
12.1 Mechanism of Action The administration of BALFAXAR provides a rapid increase in plasma levels of the vitamin K-dependent coagulation factors (FII, FVII, FIX, FX) and antithrombotic proteins C and S. Together they are referred to/known as the prothrombin complex. [ ; ] BALFAXAR can temporarily…
Pharmacologic Class:
Anti-coagulant
Clinical Trials (1)
Post Marketing Observational Study on Safety of BALFAXAR vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure
Started Feb 2025
3,574 enrolled
Vitamin K-Dependent Coagulation DefectSignificant Bleeding Risk